Stay updated on Dupilumab in Chronic Urticaria Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in Chronic Urticaria Clinical Trial page.

Latest updates to the Dupilumab in Chronic Urticaria Clinical Trial page
- CheckyesterdayChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2, signaling a minor backend update. No study content or visible features were changed.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedNew navigation/help sections were added to assist users: 'No longer looking for participants', 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'. The treatment section label was adjusted from 'Intervention / Treatment' to 'Intervention/Treatment', and the revision tag updated to v3.6.0 (replacing 3.5.5).SummaryDifference0.4%

- Check23 days agoChange DetectedThe revision label was updated from v3.5.4 to v3.5.5, indicating a minor metadata update to the page.SummaryDifference0.1%

- Check44 days agoChange DetectedThe page revision label was updated from v3.5.3 to v3.5.4, indicating a new version of the page content.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision tag updated from v3.5.2 to v3.5.3, reflecting a maintenance update to the page's software version. No study content, data, or results were modified.SummaryDifference0.1%

- Check73 days agoChange DetectedRevision: v3.5.2 was added and v3.5.0 removed. This is a site version update that does not modify study content or user actions.SummaryDifference0.1%

Stay in the know with updates to Dupilumab in Chronic Urticaria Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in Chronic Urticaria Clinical Trial page.